Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

146
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
146
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

106
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
106
Psychosurgery01:30

Psychosurgery

28
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
28
Drug Therapy01:28

Drug Therapy

32
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
32
Altered States of Awareness01:06

Altered States of Awareness

127
Altered states of consciousness represent significant deviations from one's normal mental state. These deviations can range from subtle changes in awareness to profound transformations in perception, thought processes, and sensory experiences. Altered states of consciousness can be triggered by various factors, including drug use, meditation, hypnosis, illness, or even intense fatigue.
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
127
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

98
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
98

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychedelics Trials and Outcomes- A Closer Look.

JAMA psychiatry·2026
Same author

Elective genomic sequencing for adults in research, clinical and commercial contexts.

BMC medical genomics·2026
Same author

Toward a nuanced framework for the medical development of ibogaine and its analogues and derivatives: implications for psychopharmacology.

Expert opinion on drug discovery·2026
Same author

The Psychedelic Therapies Executive Order: On Approval and Clinical Readiness.

JAMA·2026
Same author

Meeting People Where They Are: Lessons Learned from Dental Screening in Low-income Community Settings.

Progress in community health partnerships : research, education, and action·2026
Same author

Elective genomic sequencing for adults in research, clinical and commercial contexts.

medRxiv : the preprint server for health sciences·2026

Related Experiment Video

Updated: May 16, 2025

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry
11:14

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry

Published on: October 2, 2016

11.5K

On Minimizing Risk and Harm in the Use of Psychedelics.

Jules Evans1, Marc Aixalà2, Brian T Anderson3,4

  • 1The Challenging Psychedelic Experiences Project London UK.

Psychiatric Research and Clinical Practice
|April 2, 2025
PubMed
Summary

Researchers recommend enhancing psychedelic safety by identifying harms, predictors, and treatments. They advocate for increased funding and support services to build a robust psychedelic safety net.

More Related Videos

A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
08:05

A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers

Published on: January 5, 2018

9.7K
A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning
09:22

A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning

Published on: June 22, 2015

14.6K

Related Experiment Videos

Last Updated: May 16, 2025

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry
11:14

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry

Published on: October 2, 2016

11.5K
A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
08:05

A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers

Published on: January 5, 2018

9.7K
A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning
09:22

A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning

Published on: June 22, 2015

14.6K

Area of Science:

  • Psycho-pharmacology
  • Clinical Psychology
  • Public Health

Background:

  • The therapeutic potential of psychedelic substances is increasingly recognized.
  • However, significant gaps exist in understanding and mitigating associated risks.
  • A comprehensive safety framework is crucial for responsible psychedelic research and clinical application.

Purpose of the Study:

  • To identify critical research gaps concerning psychedelic harm and safety.
  • To propose recommendations for establishing a more effective psychedelic safety net.
  • To guide researchers, clinicians, and funders in prioritizing safety initiatives.

Main Methods:

  • A survey was conducted among 30 experienced psychedelic researchers.
  • Participants were asked to identify key research gaps related to psychedelic harm and safety.
  • Data analysis focused on common themes and critical areas for improvement.

Main Results:

  • Key identified gaps include defining psychedelic harm types, their predictors, and effective treatments.
  • Recommendations include enhanced support for post-psychedelic difficulties (information, peer support, therapy, psychiatric care).
  • A call for increased funding, suggesting a 1% commitment from psychedelic investments towards safety measures.

Conclusions:

  • Practical steps are outlined to improve the psychedelic safety net.
  • Increased funding for research and support services is essential.
  • Addressing knowledge gaps and implementing support systems will enhance psychedelic medicine safety.